Literature DB >> 10668473

Hyperoxia-induced cell death in the lung--the correlation of apoptosis, necrosis, and inflammation.

L L Mantell1, S Horowitz, J M Davis, J A Kazzaz.   

Abstract

Prolonged exposure to hyperoxia causes tissue damage in many organs and tissues. Since the entire surface area of lung epithelium is directly exposed to O2 and other inhaled agents, hyperoxia leads to the development of both acute and chronic lung injuries. These pathologic changes in the lung can also be seen in acute lung injury (ALI) in response to other agents. Simple strategies to mitigate hyperoxia-induced ALI might not be effective by virtue of merely reducing or augmenting the extent of apoptosis of pulmonary cells. Identification of the specific cell types undergoing apoptosis and further understanding of the precise timing of the onset of apoptosis may be necessary in order to gain a greater understanding of the connection between apoptosis and tolerance to hyperoxia and ALI. Attention should also be focused on other forms of non-apoptotic programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668473     DOI: 10.1111/j.1749-6632.1999.tb07931.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  39 in total

1.  TLR signaling prevents hyperoxia-induced lung injury by protecting the alveolar epithelium from oxidant-mediated death.

Authors:  Megan N Ballinger; Michael W Newstead; Xianying Zeng; Urvashi Bhan; Jeffrey C Horowitz; Bethany B Moore; David J Pinsky; Richard A Flavell; Theodore J Standiford
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia.

Authors:  Yan Wang; Shelley A Phelan; Yefim Manevich; Sheldon I Feinstein; Aron B Fisher
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-06       Impact factor: 6.914

3.  Cyclic stretch attenuates effects of hyperoxia on cell proliferation and viability in human alveolar epithelial cells.

Authors:  Ryan M McAdams; Shamimunisa B Mustafa; Jeffrey S Shenberger; Patricia S Dixon; Barbara M Henson; Robert J DiGeronimo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-02-03       Impact factor: 5.464

4.  An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury.

Authors:  Seyedtaghi Takyar; Yi Zhang; Maria Haslip; Lei Jin; Peiying Shan; Xuchen Zhang; Patty J Lee
Journal:  FASEB J       Date:  2015-12-11       Impact factor: 5.191

5.  Dual oxidase 2 in lung epithelia is essential for hyperoxia-induced acute lung injury in mice.

Authors:  Min-Ji Kim; Jae-Chan Ryu; Younghee Kwon; Suhee Lee; Yun Soo Bae; Joo-Heon Yoon; Ji-Hwan Ryu
Journal:  Antioxid Redox Signal       Date:  2014-06-26       Impact factor: 8.401

6.  Definition of ALI/ARDS.

Authors:  Krishnan Raghavendran; Lena M Napolitano
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

7.  Hyperoxia-derived lung damage in preterm infants.

Authors:  Vineet Bhandari
Journal:  Semin Fetal Neonatal Med       Date:  2010-04-28       Impact factor: 3.926

8.  Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs.

Authors:  Beena G Sood; Elizabeth J Dawe; Krishna Rao Maddipati; Monica Malian; Xinguang Chen; Robert Galli; Raja Rabah
Journal:  Pulm Pharmacol Ther       Date:  2008-02-06       Impact factor: 3.410

9.  The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.

Authors:  Quanfu Mao; Sravanthi Gundavarapu; Chintan Patel; Amy Tsai; Francois I Luks; Monique E De Paepe
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

10.  Anthrax infection inhibits the AKT signaling involved in the E-cadherin-mediated adhesion of lung epithelial cells.

Authors:  Taissia Popova; Virginia Espina; Charles Bailey; Lance Liotta; Emanuel Petricoin; Serguei Popov
Journal:  FEMS Immunol Med Microbiol       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.